IXHL
Incannex Healthcare Ltd ADR
Mentions (24Hr)
0.00% Today
Reddit Posts
IXHL... What in holy hell. How is this possible with such low volume??? Please help me understand.
what do you guys think of (IXHL) Incannex Healthcare
Mentions
Hello, Happy to see a lot of people making money these past few weeks again. I’m personally in ATCH, IXHL, CMND, and NFE. Happy with how they are all progressing, CMND and ATCH I will be out of whenever I get a good profit point reached.
IXHL breaking out again
I wouldn't edge IXHL with my worst enemy's mom's mouth.
IXHL ... you owe us a mega run ... come on now
IXHL is this a catalyst [https://finance.yahoo.com/news/incannex-granted-fda-fast-track-130000359.html](https://finance.yahoo.com/news/incannex-granted-fda-fast-track-130000359.html)
IXHL has real legs in the near future and long-term.
Yes it is a long term investment like FEMY. I have 17k shares of IXHL. Just chilling.
IXHL >The strategic presence of expertise from a major pharmaceutical company (Novo Nordisk) and the dominant sleep device company (ResMed) gives Incannex a significant advantage as it advances IHL-42X toward commercialization. IHL-42X achieved up to an 83% reduction in the Apnea-Hypopnea Index (AHI) from baseline in the high-dose group, along with favorable regulatory status - Fast Track designation.
IXHL earns FDA fast track designation for groundbreaking OSA Drug IHL-42X. [https://ir.incannex.com/news-releases/news-release-details/incannex-granted-fda-fast-track-designation-ihl-42x-obstructive](https://ir.incannex.com/news-releases/news-release-details/incannex-granted-fda-fast-track-designation-ihl-42x-obstructive)
IXHL being dumped in AH
I’m ready for IXHL Sqeeze
IXHL! 
thats nice i just bought a chunk & showed my crew here is my quick write up IXHL - FDA Fast Track granted TODAY for sleep apnea drug (IHL-42X). $137M cap, cannabinoid therapy, novel approach. Volume 205M (7.6x average). M&A probability 60-70%, likely Jazz Pharma/Takeda. Entry $0.45-0.48, stop $0.38, target $1.50-3.00 on buyout. Position 2-3% (spec). Fast Track = de-risked FDA path = M&A interest.
Guys Whats your thoughts on IXHL?🥳
Looking like IXHL's pattern this morning.... Maybe?
IXHL. Look at that green boner Lets go!
IXHL making some gains now. This should be much higher after this morning's news.
Does anyone else think IXHL looks bullish? Or not worth the risk
I like the potential of IXHL after hours also. Good level of insterest from the Asian market.
The exit liquidity bots are outing themselves on IXHL this morning, lol.
IXHL climbing again. Post shorters and profit takers.
You are missing IXHL from this list
Then sell it vs the miserly takes Patience takes time. If you haven't noticed many biotechs have hundreds of millions in shares outstanding. Its normal. If you see it otherwise, its because of reverse splits. Which IXHL has prevented to do.
Remember when they said don’t buy IXHL at .30, seems like a pretty sweet gain now
**IXHL's (IHL-42X) High Potential** Zepbound (tirzepatide) became the first FDA-approved drug for moderate-to-severe OSA in obese adults on Dec. 20, 2024. Zepbound's U.S. revenue reached $1.26 billion in Q3 2024 as a pre-OSA approval baseline, then **exploded to $3.57 billion in Q3 2025** - a staggering 184% year-over-year growth driven by the OSA label's prescription boost. IHL-42X treats OSA regardless of obesity, targeting the 60-70% non-obese cases (~18-20M U.S. patients). Phase 2: 51% average AHI reduction (up to 83% in responders), +25% sleep efficiency; Phase 3 starts Q4 2025. *Advantages:* - This oral pill option contrasts with Zepbound (tirzepatide), which is administered via subcutaneous injection.
IXHL is giving whiplash
Anyone jumping into IXHL?
Ok so IXHL is making me sad lol
The fact that people are profit taking on IXHL just goes to show how buns this market is I am dead
I know IXHL the company has done some less than ideal things for the stock, but an oral drug for sleep apnea seems like an epic profit machine
make the bags from IXHL and dont regret selling for profit - these fckers will dilute if they have the chance. Just like last time.
Be careful when you get into IXHL. Sure, there might be some money to be made if you time it right, but it's almost assured Joel is going to dilute the hell out of it sooner rather than later.
I sold some of my SCWO for IXHL. Shall see
Well well same company twice on my same disappointing list lol IXHL how do you manage to rug people twice in the same year! https://www.reddit.com/r/pennystocks/s/54zDicVq0u
IXHL just announced FDA fast track for sleep apnea drug shares taking off big
IXHL official PR https://ir.incannex.com/news-releases/news-release-details/incannex-granted-fda-fast-track-designation-ihl-42x-obstructive
IXHL profit taking is over and above the .5 again
Been bag holding IXHL for a while now and eventually in the green. Let’s go!
[https://finance.yahoo.com/news/incannex-granted-fda-fast-track-130000359.html](https://finance.yahoo.com/news/incannex-granted-fda-fast-track-130000359.html) finally IXHL bagholders
easy 20% on IXHL, sold, not being a bag holder :D
oh man, dropped IXHL at 0.39 to avoid becoming a bag holder.
IXHL granted fast track fda clearance 🚀🚀
What's a realistic PT for IXHL today? Think it could hit $1? Volume is rising like crazy
[$IXHL](https://x.com/search?q=%24IXHL&src=cashtag_click) 08:00 on Dec. 03 2025 Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA) Get in guys before its too late
IXHL ah ... never seen it do any moves AH though ... maybe this time ?
IXHL https://preview.redd.it/cx9hy6v1fu4g1.png?width=1066&format=png&auto=webp&s=332201df5aee58852239e9b7b5ddd3da495fa6ca volume at 12.9m vs average of 26.9... this one might be a late day runner. at least it's set up for it!
reason behind IXHL moving?
IXHL up 10% on the day
IXHL seems like a good play
IXHL -59% and NXXT -40.5% Crazy how positive news tanks stocks like crazy. Like if I told my boss I did 300% more work than last year and he fires me lol
My biggest disappointment was in myself for not taking 300% on IXHL and BURU because I had a target and not the correct exit strategy if the market was acting in opposition to my expectation. All in all that was 38k on the table. But I learned a lot and there will be another opportunity.
IXHL. They have an annual meeting on the 18th. If their end of phase 2 cleared (looking good). It will become a good momentum for commercial MOUs. Oral pill sleep apnea market is a huge unmet market.
id say IXHL, VIVK, BURU, SCWO to name a few has fcked a lot of people these past few months , and the number of people posting here have lowered drastically
MIST is next IXHL. Stop chasing other shit when this is guaranteed run up for next two weeks
IXHL ... might be a good play
IXHL- waiting on the coming results RUBI should be trading over $1 and could be $3-5 stock. Highly undervalued. Cartesi crypto(CTSI) DVLT ASST GPUS HMBL as a long long term
My biggest losers of the year: SPGC/NWTG CGTX ASST (#1 biggest loser. The scam that got me the tax breaks) BYND My biggest winners of the year: IXHL (400%+) bought at .20 and sold at 1.20 made buku thousands. CGTX is ironically in both categories NEGG VVPR had about a 75% win ratio
IXHL INCANNEX HEALTHCARE LTD . Update and vote around 13th December
What We Cannot Confirm (or is Highly Speculative): "Steadily Growing Revenue": Unconfirmed by provided data: The market data provided for SATL shows 'No. of analysts: --' and 'Avg. Estimate: --' for both earnings and revenue. This indicates a complete lack of analyst coverage in the provided dataset. While a company could have growing revenue without analyst coverage, we cannot confirm this claim using the data at hand. For a company in an emerging sector, it's not uncommon to be pre-revenue or to have highly volatile revenue in early stages. You would need to check their official financial reports (10-K, 10-Q filings) to verify their revenue growth. "Backed by the Trump administration": Speculative/Misleading phrasing: While the company has investors with ties to the Trump administration (like Steve Mnuchin) and its technology has national security implications, saying it's "backed by the Trump administration" directly is a strong claim. Government support often comes in the form of contracts or strategic importance, rather than direct "backing" of a private company by an entire administration. It's more accurate to say it has strong political connections and relevance. "Trump might buy 10% stake": Pure Speculation: There is absolutely no public information or data to support this claim. This is a highly speculative statement that should not be factored into investment decisions. "Moon like ASTS did from $2 per share to $100+ per share in a year (from April 2024 to October 2025)" and "Best stock since IXHL at 0.21 cent then it goes up to 1.73 in 2 weeks so it made 8X": Highly Speculative & Unrealistic Expectations: While it's great to have investment goals, expecting a stock to "moon" from $2 to $100+ (a 5000% gain) in such a short timeframe is extremely ambitious and statistically rare. As I mentioned before, ASTS did see significant movement, but such explosive gains are outliers. Your previous success with IXHL was fantastic, but past performance, especially rapid short-term gains, is not indicative of future results. Relying on these types of "moonshot" expectations for any stock carries very high risk. It's important to differentiate between hopeful speculation and a robust investment thesis based on fundamentals. 📊 Summary & Key Takeaways for SATL: Market Price: SATL is indeed trading under $2, currently at $1.57. High-Profile Connections: Your claims about connections to Cantor Fitzgerald/Howard Lutnick's sphere, SoftBank, and potentially Steve Mnuchin are largely consistent with public knowledge about SATL's investor base and history. Strategic Relevance: Its role in Earth Observation and its partnerships with entities like NASA, Palantir, and SpaceX highlight its strategic importance and operational capabilities in the space sector. Lack of Financial Data/Analyst Coverage: The most significant finding from the provided data is the complete absence of analyst coverage for SATL's earnings and revenue estimates. This means the market, as reflected by these data points, does not have public consensus on its financial performance or future outlook. This makes the claim of "steadily growing revenue" difficult to verify without checking the company's own financial reports. High Speculation: Many of your expectations, especially regarding price "mooning" and specific political actions (like Trump buying a stake), are highly speculative and not based on verifiable facts or reasonable projections. My advice remains: While SATL has some compelling aspects regarding its technology and connections, the lack of readily available analyst data on its financials means you'll need to do a deeper dive into their official SEC filings (like 10-K and 10-Q reports) to understand their revenue growth, profitability, and overall financial health. Always balance exciting potential with a realistic assessment of financial performance and market risks.
$IXHL in the next six months!
Maybe, maybe not. We don't actually know how Monday will go, so there is room to grow if things are looking up. I generally hold long and only trade pennies when there's some real momentum e.g. I was in IXHL and BYND, and got out before the drop. Also, I have a small position, so I'm not too pressed about it. My US stocks have been in freefall lately so I've investing locally (Nordics) over the last month.
https://ca.finance.yahoo.com/news/stonegate-updates-coverage-incannex-healthcare-143400189.html Valuation: We use a probability-adjusted Discounted Cash Flow Model when valuing **IXHL**. Our valuation model returns a valuation range of $1.32 to $1.76 with a midpoint of $1.50 based on a discount rate range of 12.50% to 17.25% and a current risk adjustment range of 13% to 18%.
IXHL rugged pretty damn hard. It ran to from like .30 to almost $2 in a couple weeks leading up to phase 2 results. The results were actually good but I literally witnessed the price tank in real time after the news came out. Total sell.the news event. It's back at .35
IXHL is my play for a bit. I decided that since everything else I touch goes to shit in this current market I might as well just eeny meeny miney mo a random stock on my watchlist and IXHL was the winner. I think due to that solid reasoning it’ll now fly 👌
MIST next IXHL, easy 5x+
Am I retarded for having IXHL as 15% of my portfolio? I’m either going to be very rich this time next year or applying for a job at Wendy’s.
Not at all. Familiarize yourself with companies, peruse here and Stocktwits(there is some useful insight to be found believe it or not). It can give you a good idea of when there is news expected within a time frame. You just have to be willing to baghold/average down accordingly. And also know when to cut your losses. IXHL and NVNI are 2 companies I’ve become familiar with over this year. I wasn’t able to successfully navigate my exit so I’m still holding and adding more here and there while playing other stocks I know less about. These 2 are both rumor/ news driven and I believe they will both pop again respectively. Although I am currently red in both, with closed positions in profit.
IXHL filings on 11/14/25 show three things: * Form 4: CFO got 869k restricted shares. No selling. * 10-Q: Cash jumped to $73M after earlier raises. Burn ~9M/quarter. Balance sheet clean, no debt overhang, no bad surprises. R&D down from timing, G&A/SBC up. * S-8: Registers 69.5M shares for the equity plan (evergreen). Not a raise, not immediate dilution. ** Reverse split: No mention, no plan, no hint anywhere in the filings.
IXHL ..... time to rise ...
IXHL, LMFA: what events will be happening today?
Anyone watching IXHL? 10q due today, possibly pre market. Any thoughts?